• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

ASCO GI: Transplant Shows Best Survival for Local Liver Cancer Therapy

Article

ORLANDO -- If all things were equal, a new liver would offer the best chance of long term survival for hepatocellular carcinoma -- but these patients make up a heterogeneous group.

ORLANDO, Jan. 22 -- If all things were equal, a new liver would offer the best chance of long term survival for hepatocellular carcinoma.

So said Roderich Schwarz, M.D., of the Cancer Institute of New Jersey in New Brunswick, who compared survival for three local treatment strategies -- transplant, surgical resection, and ablation.

After five years, the survival rate for transplant patients was 67%, versus 38% for those who had surgical resection and 19% for ablation procedures (P

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
© 2024 MJH Life Sciences

All rights reserved.